Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Pediatr. aten. prim ; 18(72): e149-e172, oct.-dic. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-158701

ABSTRACT

Entre las infecciones por hongos, las micosis superficiales, adquiridas por contacto directo o indirecto con un animal o con una persona infectados, son las más habituales en la infancia. Los patógenos más frecuentes en el niño inmunocompetente son las levaduras (Candida y Malasezzia) y los dermatofitos. La morbilidad de las micosis superficiales es tan importante como poco considerada, pues existe la falsa impresión de que constituyen un problema menor pese a su gran incidencia en la práctica habitual. En el presente documento de consenso, elaborado por el Grupo de Trabajo de Infecciones de Manejo Ambulatorio de la Sociedad Española de Infectología Pediátrica (SEIP), la Asociación Española de Pediatría de Atención Primaria (AEPap) y la Sociedad Española de Pediatría Extrahospitalaria y Atención Primaria (SEPEAP), se abordan los aspectos esenciales de la infección micótica superficial en el niño inmunocompetente (AU)


Superficial mycoses, acquired by direct or indirect contact with an infected animal or person, are frequent in childhood. The most common pathogens in immunocompetent children are yeasts (Candida and Malasezzia) and dermatophytes. The morbidity of the superficial mycoses is as important as trivialized, which gives the false impression that it constitutes a minor problem despite its high incidence in routine practice. In this consensus document of the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Primary Care Pediatrics (AEPap) and the Spanish Society of Pediatric Outpatient and Primary Care (SEPEAP), the essential aspects of superficial fungal infection in the immunocompetent child are addressed (AU)


Subject(s)
Humans , Male , Female , Child , Mycoses/drug therapy , Mycoses/etiology , Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Candidiasis/etiology , Tinea/drug therapy , Tinea/etiology , Tinea Capitis/drug therapy , Tinea Capitis/etiology , Consensus Development Conferences as Topic , Societies, Medical/organization & administration , Societies, Medical/standards , Mycoses/classification , Mycoses/diagnosis , Onychomycosis/epidemiology , Tinea Pedis/drug therapy , Tinea Pedis/epidemiology , Tinea Pedis/etiology , Onychomycosis/drug therapy , Onychomycosis/etiology
2.
An Pediatr (Barc) ; 84(2): 121.e1-121.e10, 2016 Feb.
Article in Spanish | MEDLINE | ID: mdl-25735876

ABSTRACT

Skin infections are a common cause for dermatological consultations in the paediatric setting. A review is presented of the clinical manifestations, diagnosis and treatment of the main bacterial skin infections, as well as the diagnosis and treatment of super-infected puncture and bite wounds. The most prevalent bacteria in skin infections are Staphylococcus aureus and Streptococcus pyogenes. Treatment is usually empirical, since microbiological studies are only recommended under certain circumstances or lack of improvement with common therapies. Superficial skin infections can be treated with local antiseptics or antibiotics (mupirocin or fusidic acid). Systemic treatment is usually reserved for patients with extensive or severe disease or with other risk factors. Systemic treatment depends on the suspected infecting bacteria, with penicillin, amoxicillin, amoxicillin-clavulanic acid and first or second generation cephalosporin being the most frequently used drugs. Due to the low incidence of community-acquired methicillin-resistant infection by S. aureus in Spain, the use of clindamycin or co-trimoxazole is only recommended after severe disease, relapses or a clear epidemiological background.


Subject(s)
Staphylococcal Skin Infections/diagnosis , Staphylococcal Skin Infections/therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/therapy , Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Community-Acquired Infections/drug therapy , Consensus , Humans , Outpatients , Pediatrics , Spain , Staphylococcus aureus , Streptococcus pyogenes
SELECTION OF CITATIONS
SEARCH DETAIL
...